EP0877623A4 - - Google Patents

Info

Publication number: EP0877623A4
Authority: EP; European Patent Office
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP96924312A

Other versions

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-07

Filing date

1996-06-26

Publication date

1998-11-18

1996-06-26 Application filed filed Critical

1998-11-18 Publication of EP0877623A4 publication Critical patent/EP0877623A4/xx

1998-11-18 Publication of EP0877623A1 publication Critical patent/EP0877623A1/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

EP96924312A 1995-07-07 1996-06-26 Intranasal vaccination against gastrointestinal disease Withdrawn EP0877623A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US49922995A	1995-07-07	1995-07-07
US499229		1995-07-07
PCT/US1996/010987 WO1997002835A1 (en)	1995-07-07	1996-06-26	Intranasal vaccination against gastrointestinal disease

Publications (2)

Publication Number	Publication Date
EP0877623A4 true EP0877623A4 (en)	1998-11-18
EP0877623A1 EP0877623A1 (en)	1998-11-18

Family

ID=23984386

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP96924312A Withdrawn EP0877623A1 (en)	1995-07-07	1996-06-26	Intranasal vaccination against gastrointestinal disease

Country Status (8)

Country	Link
EP (1)	EP0877623A1 (en)
JP (1)	JPH11510793A (en)
CN (1)	CN1195993A (en)
AU (1)	AU722653B2 (en)
CA (1)	CA2226392A1 (en)
NZ (1)	NZ312876A (en)
WO (1)	WO1997002835A1 (en)
ZA (1)	ZA965737B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6153201A (en) *	1993-03-09	2000-11-28	University Of Rochester	Oral immunization with papillomavirus virus-like particles
US6969520B2 (en)	1997-10-20	2005-11-29	Acambis Inc.	Active immunization against clostridium difficile disease
US6585975B1 (en) *	1998-04-30	2003-07-01	Acambis, Inc.	Use of Salmonella vectors for vaccination against helicobacter infection
CA2389582C (en) *	1999-11-01	2010-08-31	Muco Vax B.V.	Production of mammary secretion antibodies in farm animals
US7074454B1 (en)	1999-11-01	2006-07-11	Mucovax Holding B.V.	Production of mammary secretion antibodies in farm animals
US6974573B2 (en)	1999-11-01	2005-12-13	Mucovax Holdings, B.V.	Antibody production in farm animals
GB0029919D0 (en) *	2000-12-07	2001-01-24	Chiron Spa	Helicobacter pylori prime & boost vaccination
EP2161035B1 (en) *	2007-05-28	2019-08-21	Daiichi Sankyo Company, Limited	Bordetella parapertussis-containing whole-cell vaccine composition
JP5503543B2 (en) *	2007-09-14	2014-05-28	サノフィパスツールバイオロジクスリミテッドライアビリティカンパニー	Pharmaceutical composition containing Clostridium difficile toxoid A and B
MX2011005758A (en) *	2008-12-03	2011-06-28	Boehringer Ingelheim Vetmed	Process for production of vaccines.
EP2519257A4 (en) *	2009-12-02	2014-10-15	Univ Tufts	Atoxic recombinant holotoxins of clostridium difficile as immunogens
SI2699587T1 (en)	2011-04-22	2019-08-30	Wyeth Llc	Compositions relating to a mutant clostridium difficile toxin and methods thereof
CA2856085C (en)	2011-11-18	2020-06-30	National Research Council Of Canada	Clostridium difficile lipoteichoic acid and uses thereof
BR122016023101B1 (en)	2012-10-21	2022-03-22	Pfizer Inc	Polypeptide, immunogenic composition comprising it, as well as recombinant cell derived from Clostridium difficile

Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4141970A (en) *	1975-05-07	1979-02-27	Internationale Octrooimaatschappij "Octropa" B.V.	Method for enhancing the resistance of new born mammalian young to gastro-intestinal infections
US4713240A (en) *	1985-04-04	1987-12-15	Research Corporation	Vaccines based on insoluble supports
WO1993021950A1 (en) *	1992-04-28	1993-11-11	Medeva Holdings Bv	Vaccine compositions for mucosal delivery
WO1994002173A1 (en) *	1992-07-16	1994-02-03	Oxford University	Multiple particulate antigen delivery system

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4944942A (en) *	1987-08-27	1990-07-31	Mobay Corporation	Intranasal vaccination of horses with inactivated microorganisms or antigenic material
JP2849632B2 (en) *	1988-04-08	1999-01-20	社団法人北里研究所	Vaccine preparation
US5601823A (en) *	1989-10-31	1997-02-11	Ophidian Pharmaceuticals, Inc.	Avian antitoxins to clostridium difficle toxin A

1996
- 1996-06-26 CN CN96196763A patent/CN1195993A/en active Pending
- 1996-06-26 NZ NZ312876A patent/NZ312876A/en unknown
- 1996-06-26 WO PCT/US1996/010987 patent/WO1997002835A1/en not_active Application Discontinuation
- 1996-06-26 EP EP96924312A patent/EP0877623A1/en not_active Withdrawn
- 1996-06-26 JP JP9505849A patent/JPH11510793A/en active Pending
- 1996-06-26 CA CA002226392A patent/CA2226392A1/en not_active Abandoned
- 1996-06-26 AU AU64799/96A patent/AU722653B2/en not_active Ceased
- 1996-07-05 ZA ZA965737A patent/ZA965737B/en unknown

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4141970A (en) *	1975-05-07	1979-02-27	Internationale Octrooimaatschappij "Octropa" B.V.	Method for enhancing the resistance of new born mammalian young to gastro-intestinal infections
US4713240A (en) *	1985-04-04	1987-12-15	Research Corporation	Vaccines based on insoluble supports
WO1993021950A1 (en) *	1992-04-28	1993-11-11	Medeva Holdings Bv	Vaccine compositions for mucosal delivery
WO1994002173A1 (en) *	1992-07-16	1994-02-03	Oxford University	Multiple particulate antigen delivery system

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE MEDLINE WALDO FB: "Nasal immunization with tetanus toxoid increases the subsequent systemic dimeric IgA1 antibody response to intramuscular immunization", XP002063192 *
JOURNAL OF CLINICAL AND LABORATORY IMMUNOLOGY, 1991, 34(3) 125-129 *
LIBBY J.M. ET AL: "Effects of the two toxins of Clostridium difficile in antibiotic associated cecitis in hamsters", INFECTION AND IMMUNITY, vol. 36, no. 2, 1982, WASHINGTON US, pages 822 - 829, XP002063191 *
See also references of WO9702835A1 *

Also Published As

Publication number	Publication date
AU722653B2 (en)	2000-08-10
NZ312876A (en)	2000-06-23
CA2226392A1 (en)	1997-01-30
CN1195993A (en)	1998-10-14
AU6479996A (en)	1997-02-10
WO1997002835A1 (en)	1997-01-30
JPH11510793A (en)	1999-09-21
ZA965737B (en)	1997-05-13
EP0877623A1 (en)	1998-11-18

Legal Events

Date	Code	Title	Description
1998-10-02	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1998-11-18	17P	Request for examination filed	Effective date: 19980115
1998-11-18	A4	Supplementary search report drawn up and despatched	Effective date: 19980522
1998-11-18	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB IE IT LI NL SE Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB IE IT LI NL SE
1999-02-10	17Q	First examination report despatched	Effective date: 19981223
2002-02-15	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2002-04-03	18D	Application deemed to be withdrawn	Effective date: 20010921

Publication	Publication Date	Title
DE69638352D1 (en)	2011-05-19
DE69637714D1 (en)	2008-11-27
BRPI9612258B1 (en)	2011-05-31
BRPI9612138B1 (en)	2009-09-22
ECSDI950232S (en)	1996-01-29
CH0741373H1 (en)	2011-10-14
DK0727898T3 (en)	1997-03-17
BR7502120U (en)	1998-04-14
BR7501503U (en)	1997-11-25
ECSDI950233S (en)	1996-01-29
ECSDI950223S (en)	1996-01-29
ECSDI950231S (en)	1996-01-29
ECSDI950230S (en)	1996-07-16
ECSDI950229S (en)	1996-01-29
IN182904B (en)	1999-08-07
AU1627395A (en)	1995-06-30
DK126096A (en)	1996-11-08
IN176619B (en)	1996-08-10
CN3033635S (en)	1995-07-19
CN3035871S (en)	1995-10-04
CN3032390S (en)	1995-06-07
CN3032568S (en)	1995-06-14
CN3032692S (en)	1995-06-14
CN3033225S (en)	1995-07-05
CN3031742S (en)	1995-05-10